Shanghai RAAS Blood Products Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai RAAS Blood Products has a total shareholder equity of CN¥31.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥33.4B and CN¥2.2B respectively. Shanghai RAAS Blood Products's EBIT is CN¥2.3B making its interest coverage ratio -8.5. It has cash and short-term investments of CN¥3.7B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -8.5x |
| Cash | CN¥3.71b |
| Equity | CN¥31.17b |
| Total liabilities | CN¥2.19b |
| Total assets | CN¥33.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002252's short term assets (CN¥9.1B) exceed its short term liabilities (CN¥2.2B).
Long Term Liabilities: 002252's short term assets (CN¥9.1B) exceed its long term liabilities (CN¥26.8M).
Debt to Equity History and Analysis
Debt Level: 002252 is debt free.
Reducing Debt: 002252 had no debt 5 years ago.
Debt Coverage: 002252 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 002252 has no debt, therefore coverage of interest payments is not a concern.